10x Genomics, Inc. — Director's Dealing 2021

Mar 16, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: 10x Genomics, Inc. (TXG)
CIK: 0001770787
Period of Report: 2021-03-12

Reporting Person: Hindson Benjamin J. (Director, See Remarks, 10% Owner)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-03-12	Class A Common Stock	M	36364	$0.88	Acquired	73000	Direct
2021-03-12	Class A Common Stock	M	5302	$1.07	Acquired	78302	Direct
2021-03-12	Class A Common Stock	S	6023	$154.5554	Disposed	72279	Direct
2021-03-12	Class A Common Stock	S	8074	$155.5381	Disposed	64205	Direct
2021-03-12	Class A Common Stock	S	8189	$156.4468	Disposed	56016	Direct
2021-03-12	Class A Common Stock	S	5845	$157.4768	Disposed	50171	Direct
2021-03-12	Class A Common Stock	S	6368	$158.6405	Disposed	43803	Direct
2021-03-12	Class A Common Stock	S	7167	$159.3953	Disposed	36636	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-03-12	Stock Option (right to buy)	$0.88	M	36364	Disposed	2025-10-27	Class A Common Stock (36364)	Direct
2021-03-12	Stock Option (right to buy)	$1.07	M	5302	Disposed	2026-11-18	Class A Common Stock (5302)	Direct

Footnotes

F1: The option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person.

F2: This transaction was executed in multiple trades at prices ranging from $154.00 to $154.985. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.

F3: This transaction was executed in multiple trades at prices ranging from $155.01 to $156.00. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.

F4: This transaction was executed in multiple trades at prices ranging from $156.005 to $156.95. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.

F5: This transaction was executed in multiple trades at prices ranging from $157.02 to $158.01. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.

F6: This transaction was executed in multiple trades at prices ranging from $158.02 to $159.00. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.

F7: This transaction was executed in multiple trades at prices ranging from $159.03 to $159.97. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.

F8: All of the shares subject to the option are fully vested and exercisable as of the date hereof.

F9: This option, originally for 125,000 shares, of which 5,302 shares have been exercised, vested as to one-fourth of the shares on August 1, 2017, and one forty-eighth of the shares subject to the option vest each month thereafter, subject to the Reporting Person continuing as a service provider through each such date.